亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Acupuncture and Acupoints for Low Back Pain: Systematic Review and Meta-Analysis

针灸科 医学 荟萃分析 腰痛 物理疗法 随机对照试验 临床试验 替代医学 外科 内科学 病理
作者
Geesung Kim,Dong-Won Kim,Heeyoung Moon,Da-Eun Yoon,Seoyoung Lee,Seok‐Jae Ko,Bonglee Kim,Younbyoung Chae,In‐Seon Lee
出处
期刊:The American Journal of Chinese Medicine [World Scientific]
卷期号:51 (02): 223-247 被引量:40
标识
DOI:10.1142/s0192415x23500131
摘要

Acupuncture has been used as a therapeutic intervention for the treatment of numerous diseases and symptoms for thousands of years, and low back pain has been studied and treated the most in acupuncture clinics. Traditional theory strongly suggests that the selection of acupoints will influence their clinical effects and combinations (e.g., the clinical effects of a particular acupoint or combination on reducing pain), but this idea was not considered in earlier systematic reviews and meta-analyses. We performed a systematic review, meta-analysis, and network analysis to evaluate the magnitude of the effects of acupoints used to treat low back pain in randomized controlled clinical trials. We found that acupuncture significantly reduced pain in patients with low back pain compared with the control group. The most frequently prescribed acupoints were BL23, GV3, BL20, BL40, and BL25, whereas the acupoints with the highest average effect size scores were BL20, GV3, GB30, GB34, and BL25. Further, the combinations of BL23-BL40, BL23-B25, and BL23-BL60 were the most frequently prescribed, while BL23-GV3, BL40-GV4, and BL23-BL25 showed the largest average effect size. By calculating clinical outcomes based on average effect sizes, we found that the most popular acupoints might not always be associated with the best results. Although a more thorough investigation is necessary to determine the clinical effects of each acupoint and combination on patients, we suggest that our approach may offer a fresh perspective that will be useful for future research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小新完成签到 ,获得积分10
7秒前
Akim应助科研通管家采纳,获得10
20秒前
20秒前
20秒前
20秒前
倪妮发布了新的文献求助10
59秒前
倪妮完成签到,获得积分10
1分钟前
芝士酱完成签到,获得积分10
1分钟前
2分钟前
2分钟前
2分钟前
2分钟前
洲洲发布了新的文献求助10
2分钟前
星星发布了新的文献求助10
2分钟前
2分钟前
自律发布了新的文献求助10
2分钟前
XIAJIN完成签到,获得积分10
2分钟前
量子星尘发布了新的文献求助150
2分钟前
electricelectric完成签到,获得积分10
3分钟前
星星发布了新的文献求助10
3分钟前
自律完成签到,获得积分10
3分钟前
Lexi完成签到 ,获得积分10
3分钟前
星星发布了新的文献求助10
4分钟前
4分钟前
神勇绮琴发布了新的文献求助10
4分钟前
4分钟前
4分钟前
田様应助洲洲采纳,获得10
4分钟前
4分钟前
zzzzz完成签到 ,获得积分10
5分钟前
黄桃发布了新的文献求助10
5分钟前
胡萝卜完成签到,获得积分10
5分钟前
科研通AI5应助洁净的千凡采纳,获得30
5分钟前
5分钟前
6分钟前
科研通AI5应助ycliang采纳,获得10
6分钟前
nessa完成签到 ,获得积分10
6分钟前
科研通AI6应助科研通管家采纳,获得10
6分钟前
打打应助科研通管家采纳,获得10
6分钟前
6分钟前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5137486
求助须知:如何正确求助?哪些是违规求助? 4337281
关于积分的说明 13511327
捐赠科研通 4175861
什么是DOI,文献DOI怎么找? 2289760
邀请新用户注册赠送积分活动 1290277
关于科研通互助平台的介绍 1232004